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Summary
Odorant identity is represented in the olfactory bulb
(OB) by the glomerular activity pattern, which reflects
a combination of activated odorant receptors (ORs) in
the olfactory epithelium. To elucidate this neuronal cir-
cuit at the molecular level, we established a functional
OR identification strategy based on glomerular activ-
ity by combining in vivo Ca2+ imaging, retrograde
dye labeling, and single-cell RT-PCR. Spatial and func-
tional mapping of OR-defined glomeruli revealed that
the glomerular positional relationship varied consid-
erably between individual animals, resulting in differ-
ent ORmaps in the OB. Notably, OR-defined glomeruli
exhibited different ligand spectra and far higher sensi-
tivity compared to the in vitro pharmacological proper-
ties of corresponding ORs. Moreover, we found that
the olfactorymucuswas an important factor in the reg-
ulation of in vivo odorant responsiveness. Our results
provide a methodology to examine in vivo glomerular
responses at the receptor level and further help ad-
dress the long-standing issues of olfactory sensitivity
and specificity under physiological conditions.
Introduction
The mammalian olfactory system has a remarkable abil-
ity to discriminate a wide variety of odorants (Buck,
2004; Firestein, 2004; Mombaerts, 2004; Touhara,
2002). The odorant information received by olfactory
sensory neurons (OSNs) in the olfactory epithelium
(OE) is integrated into the primary olfactory center, the
olfactory bulb (OB), and further transmitted to the olfac-
*Correspondence: touhara@k.u-tokyo.ac.jp
5 Present address: The Rockefeller University, 1230 York Avenue,
New York, New York 10021.tory cortex in which olfactory perception is constructed
(Buck, 2004; Mori et al., 2006; Xu et al., 2003). The initial
step of olfaction is the binding of volatile compounds to
odorant receptors (ORs), which include approximately
1000 members of the G protein-coupled receptor super-
family (Buck and Axel, 1991). Each OSN expresses only
a single OR gene (Chess et al., 1994; Serizawa et al.,
2000); therefore, the OR plays a pivotal role in defining
the odorant responsiveness of individual OSNs in
the OE.
Since the OR gene superfamily has been discovered,
the ligands for more than 20 ORs have been identified
using various heterologous expression systems (Kajiya
et al., 2001; Saito et al., 2004; Shirokova et al., 2005; Wet-
zel et al., 1999) or isolated OSNs expressing a particular
OR of interest (Bozza et al., 2002; Malnic et al., 1999;
Touhara et al., 1999). Each OR possesses a relatively
broad ligand spectrum with a low ligand affinity and rec-
ognizes a distinct but sometimes overlapping set of
odorants (Araneda et al., 2000; Katada et al., 2005; Luu
et al., 2004). For example, the MOR174-9 gene encodes
the mouse OR for eugenol (mOR-EG), which has been
shown to recognize approximately 25 structurally re-
lated agonists and three antagonists with different po-
tencies when expressed in HEK293 cells (Kajiya et al.,
2001; Katada et al., 2005; Oka et al., 2004a, 2004b).
These extensive studies on individual ORs have demon-
strated that each OR recognizes more than one odorant
and that each odorant is recognized by a unique combi-
nation of ORs, suggesting that odor quality is deter-
mined by a combinatorial receptor-coding scheme.
Odorant representation in the OB has been examined
extensively using several imaging methods (Fried et al.,
2002; Rubin and Katz, 1999; Uchida et al., 2000; Wacho-
wiak and Cohen, 2001; Xu et al., 2000) and using various
neuronal activity markers (Guthrie and Gall, 1995; John-
son and Leon, 2000). Individual odorants activate dis-
tinct subsets of glomeruli in a stereotyped region of
the OB, resulting in the construction of a glomerular ac-
tivation pattern that is unique for each odorant. Anatom-
ical and molecular evidence indicates that approxi-
mately 10,000 OSNs expressing the same OR send
their axons to a few topographically fixed glomeruli in
the OB, indicating that the pattern of activated glomeruli
reflects the combination of activated ORs in the OE
(Mombaerts et al., 1996; Ressler et al., 1994; Vassar
et al., 1994). Thus, odorant molecular features decoded
in the OE are translated to a spatial glomerular activity
pattern, which is called the ‘‘odor map’’ (Mori et al.,
2006; Shepherd, 1994).
Despite increasing information on odorant-OR inter-
actions in peripheral OSNs and spatial odorant repre-
sentations in the OB, gene-targeting and transgenic
techniques have been required for exploring the projec-
tion, positional patterns, and in vivo responses of OR-
defined glomeruli (Belluscio et al., 2002; Mombaerts
et al., 1996; Serizawa et al., 2000; Strotmann et al., 2000;
Zheng et al., 2000). Because of the difficulty in deter-
mining the OR repertoire expressed in odorant-activated
glomeruli in the OB, a comprehensive understanding
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858Figure 1. Recording of Odorant Responses
in the mOR-EG Glomerulus
(A) Genomic structure of the mOR-EG gene
fragment used for transgenic mice. The
9.4 kb fragment containing the putative tran-
scription start site (TSS) 2.6 kb upstream of
the ATG was substituted for the targeting
vector and transgene construction.
(B) Dorsal view of the left and right OB (dotted
line) in the TgC transgenic mouse line. GFP
signals are visible in the mOR-EG glomerulus.
ant, anterior; lat, lateral. Scale bar, 500 mm.
(C) Sections of the OB from mOR-EG trans-
genic mice (TgC) stained for neuronal marker,
NCAM (red) or with DNA staining reagent,
DAPI (blue). The main GFP-positive glomeru-
lus was exclusively innervated by GFP-
expressing OSNs.
(D) Dose-dependent responses of the mOR-
EG glomerulus to EG. Response of the
mOR-EG glomerulus to EG were examined
by Ca2+ imaging (upper) or intrinsic imaging
(middle). The time course of the fluorescent
(Ca2+, upper left) or reflectance (intrinsic,
middle left) signal was plotted. Horizontal
dashed lines indicate the baseline for each
signal. Odor stimulation periods (3 s for
Ca2+; 5 s for intrinsic) are indicated by shaded
boxes. The change in fluorescence or reflec-
tance intensities before and after application
of each stimulus is shown in pseudocolored
(Ca2+) or grayscale (intrinsic) images, wherein
red or black correspond to the greatest re-
sponse. Scale bar, 30 mm. The responses to
different concentrations of EG were quanti-
fied and are shown as a percentage of the
maximum response and fitted to the dose-
response curve (bottom, 6SE, n = 3–4).of how the odor map is formed at the molecular level
has not yet been obtained. Due to this technical limita-
tion, whether the odor map in the OB truly corresponds
to the receptor code in the OE has not yet been deter-
mined.
To address this issue, using mOR-EG transgenic mice,
we established a technique to identify OR genes that are
expressed in OSNs innervating glomeruli activated by
a given odorant. We then examined the detailed func-
tional and spatial characteristics of OR-defined glomer-
uli in the mouse OB as well as the relationship between
the pharmacology of ORs in isolated OSNs and the
responsiveness of the corresponding glomeruli. OR-
defined glomeruli exhibited different ligand spectra and
far higher sensitivity compared to the pharmacological
properties of ORs demonstrated in vitro. Moreover, we
provide evidence that the olfactory mucus is an impor-
tant factor regulating the odorant responsiveness of ORs
in vivo. Our results provide important insights into the
mechanisms underlying the formation of odorant repre-
sentation in the OB under physiological conditions at the
receptor level.
Results
mOR-EG Transgenic Mice
To investigate the odorant response of a glomerulus
innervated by mOR-EG-expressing neurons, we gener-
ated transgenic mice carrying a mOR-EG-IRES-gapEGFPtransgene. A 9.4 kb mOR-EG genomic fragment contain-
ing 3.0 kb upstream of transcription start sites and 1.4 kb
downstream of the coding region was used to construct
the transgene (Figure 1A). The IRES sequence allows
for coexpression of an OR with a reporter protein. We ob-
tained three transgenic lines (TgA, TgB, and TgC) with
a strong green fluorescent protein (GFP) signal in the
OB (see Figure S1 in the Supplemental Data available
online). Although the number of GFP-positive OSNs
varied between the three lines, GFP-labeled neurons
were always distributed within the most dorsal part of the
OE (zone 1) where endogenous mOR-EG is expressed
(Oka et al., 2004b) (Figure S1).
The main GFP-positive glomerulus (mOR-EG glomer-
ulus) was invariably located in the antero-lateral region
of the dorsal OB in all lines, while a few small additional
glomeruli were observed in some lines (Figures 1B and
S1). The variations between the three lines are likely
due to the copy number or locus where the transgene
was inserted as previously shown for MOR23 (Vassalli
et al., 2002). Immunohistological staining of the OB
coronal sections revealed that the main fluorescent
glomerulus was exclusively innervated by GFP-express-
ing OSNs in all lines (Figure 1C). Transgene-derived
mOR-EG was not coexpressed with the endogenous
mOR-EG gene in OSNs (data not shown), indicating
that the 9.4 kb genomic fragment was sufficient to
ensure mutually exclusive expression of the mOR-EG
transgene.
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Glomerulus
Next, we examined the odorant response of the main
glomerulus in mOR-EG transgenic mice. The OB was il-
luminated at 650 nm for intrinsic imaging or at 540 6
15 nm for Calcium Green (CG)-1-based Ca2+ imaging un-
der freely breathing conditions (w2.5 Hz). Stimulation
with 180 nM EG (10% dilution) elicited a maximum
Ca2+ signal (DF/F = 2.5% 6 0.3%; n = 12) and intrinsic
signal (DI/I = 0.09% 6 0.01%; n = 9) (Figure 1D). The re-
sponse amplitudes in the mOR-EG glomerulus in-
creased in a dose-dependent manner, with an EC50 of
59 nM (1.0% dilution) for Ca2+ imaging and 74 nM
(1.5% dilution) for intrinsic imaging (Figure 1D, bottom).
Threshold vapor concentrations were between 20 and
60 nM for both Ca2+ and intrinsic imaging. Notably, the
EC50 value of the mOR-EG glomerulus for EG was
w1000-fold lower than that obtained in HEK293 cells
(46 mM) or mOR-EG-expressing isolated OSNs (51 mM)
(see Figure 7). We observed no differences in odorant
responsiveness between transgenic and endogenous
mOR-EG glomeruli (data not shown).
Retrograde Dye Labeling for Functional OR Cloning
Each odorant activates a distinct subset of glomeruli in
the OB, which is supposed to reflect a receptor code
for an odorant in the OE. To elucidate the neuronal cir-
cuit at the molecular level and to determine which OR
genes are expressed in activated glomeruli, we next es-
tablished a functional OR-cloning methodology based
on in vivo glomerular activity by combining three tech-
niques: Ca2+ imaging, retrograde dye labeling, and
single-cell RT-PCR.
To establish this methodology, we took advantage of
mOR-EG transgenic mice whose mOR-EG glomerulus
can be visualized with GFP. We injected DiI into a
mOR-EG glomerulus for retrograde labeling of the cell
bodies of OSNs expressing mOR-EG (Figure 2A, upper
row; n = 3 mice). Dye injection was performed by using
the GFP signal to identify the precise location of glo-
merulus. Less than 0.1 ml of 3% DiI (w/v) in dimethyl
formamide was pressure-injected via a glass micro-
capillary tube with a diameter of w2 mm. The injection
size was typically 50% to 80% of a single glomerulus,
depending on the size of the target glomerulus. Under
these conditions, ‘‘contamination’’ with DiI in nontar-
geted glomeruli or surface nerve layers was minimized.
Thus, the average size of the injected area in mOR-EG
transgenic mice was 84.4 6 7.3 mm (n = 3) in diameter,
because the diameter of the GFP-positive mOR-EG glo-
merulus was 168 6 9 mm (n = 8, TgA), which was larger
than the intact glomerular size due to transgene expres-
sion (Figure 2A, upper row). Twenty-four to 36 hr after in-
jection, 72%6 11% (n = 3) of DiI-labeled OSNs in the OE
were GFP positive (Figure 2A, bottom row), and 51% 6
9% (n = 3) of GFP-positive cells were stained with DiI.
These results indicate that the majority, but not all, of
DiI-stained cells expressed mOR-EG. A higher amount
of DiI or a larger diameter capillary tube increased the
number of labeled OSNs that innervated nontargeted
glomeruli. Next, we isolated DiI-stained cells and con-
firmed mOR-EG expression by single-cell RT-PCR in
6 out of 9 stained cells (Figure 2B). Because the mOR-
EG gene was amplified from all GFP-positive OSNs(12 out of 12 cells; data not shown), the three remaining
DiI-stained OSNs appear to express other OR genes.
Thus, the optimized methodology could identify a target
OR gene in approximately 70% of DiI-stained cells.
Functional Identification of ORs in Odorant-
Responsive Glomeruli
Stimulation with EG, methyl isoeugenol (MIEG), and
isovaleric acid (IVA) elicited dose-dependent Ca2+
increases in distinct subsets of glomeruli in the dorsal
OB (Figure 3). The threshold concentrations of these
odorants were between 1029 and 1028 M in the air
phase. Increasing odorant concentrations resulted in
activation of additional glomeruli. We found three glo-
meruli that exhibited lower EC50 values for EG than the
mOR-EG glomerulus in the dorsal OB (EC50 = 6.5, 14,
and 26 nM for glomeruli Ea, Eb, and Ec; Figure 3A).
The Ea glomerulus (glom. Ea), which was the most sen-
sitive to EG, also responded to MIEG at concentrations
as low as 1 nM (EC50 = 3.3 nM; Figures 3A and 3B).
The Ma glomerulus (glom. Ma) showed a response to
MIEG with an EC50 value of 2.3 nM (n = 5) but not to
EG (Figure 3B). Glomerulus Ia (glom. Ia) was one of the
most IVA-sensitive glomeruli, with an EC50 value of
97 nM, and was located in the medial-posterior region
of the dorsal OB (Figure 3C).
To identify the ORs that are expressed in these glo-
meruli, we adopted the functional OR cloning method
that was established using mOR-EG transgenic mice.
First, we used degenerate primers to identify OR genes
from DiI-positive isolated OSNs (Table S1). Next, spe-
cific primers were generated for the most frequently
Figure 2. Retrograde Dye Labeling of OSNs Innervating a Defined
Glomerulus
(A) Injection of DiI solution into the mOR-EG glomerulus. Left, a dia-
gram of the DiI injection. Top right, 3% DiI solution in DMF was pres-
sure-injected into the center of an mOR-EG glomerulus using the
GFP signal as an indicator. Bottom right, an intact OE 24 hr after
DiI injection. The GFP, DiI, and merged signals are shown in the
left, middle, and right columns, respectively. Scale bar, 100 mm (up-
per row) or 30 mm (lower row).
(B) Single-cell RT-PCR of DiI-stained OSNs. OSNs stained with DiI
(left) were individually collected and analyzed by RT-PCR (right).
Numbers shown in red indicate OSNs from which the mOR-EG
gene was amplified using mOR-EG specific primers.
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Functionally Identified Glomeruli
Shown are odorant response maps evoked
by EG (A), MIEG (B), and IVA (C). Higher con-
centrations of odorants activated larger pop-
ulations of glomeruli. EG and MIEG activate
overlapping sets of glomeruli in the dorso-
lateral region (A and B), whereas IVA acti-
vates distinct subsets of glomeruli in the
dorso-medial region (C). In all panels, the va-
por concentrations (nM) and dilution rate (%
in mineral oil) are shown above the pseudo-
colored images. The pseudocolored images
show the change in fluorescent intensities
before and after odor stimulation is shown,
wherein red corresponds to the greatest
response. The graphs show the dose-
response curves for each glomerulus. The
dashed boxes indicate the position of the
magnified images from each response map.
Odorant responses are shown as a percent-
age of the maximum response of each glo-
merulus and are fitted to the dose-response
curve (6SE, n = 3).amplified OR genes (one to four genes for each glomer-
ulus), and PCR amplification was performed on the
same set of samples. An OR that was amplified from typ-
ically more than half of the population was considered
as a candidate OR. For example, using degenerate
primers, the MOR224-9 gene was amplified from 3 of
34 DiI-positive OSNs obtained by injection of DiI into
glom. Ea (Table S1), and we confirmed the expression
of this gene in 16 out of the 34 cells using specific
primers (Figure 4A). In the same way, we cloned the
MOR224-5 gene (19/34 cells from 7 mice) from OSNs in-
nervating glomerulus Eb (glom. Eb), the MOR224-13
gene (9/13 cells from 3 mice) from glomerulus Ec (glom.
Ec), and the MOR204-34 gene (10/14 cells from 3 mice)
from glom. Ma using specific primers (Figure 4A).
A single OR gene was always amplified from a single
isolated OSN using specific or degenerate primers.
MOR224-9, MOR224-5, and MOR224-13 belong to thesame subfamily, with 65%–93% amino acid sequence
identity. For glom. Ia, out of 17 DiI-positive OSNs, we
identified the MOR31-2 gene in nine cells by using de-
generate primers and confirmed the expression of
MOR31-2 in ten cells with specific primers (Figure 4A).
MOR31-2 turned out to be the S18 receptor, which has
previously been shown to be a receptor for carboxylic
acid (Malnic et al., 1999; Saito et al., 2004).
We performed two independent experiments to con-
firm that the identified ORs really confer odorant respon-
siveness to the glomeruli. First, because a small amount
of OR mRNAs are transported to the axon terminal of
OSNs in the OB (Ressler et al., 1994; Vassar et al.,
1994), we sucked up the activated glomerulus and di-
rectly performed single glomerulus RT-PCR (Figure 4B).
We were able to precisely locate the single target glo-
merulus using the CG-1 signal as a landmark. To prevent
contamination from axons expressing a nontarget OR,
In Vivo Odorant Receptor Pharmacology
861Figure 4. Identification of OR Genes Expressed in OSNs Innervating Odorant-Activated Glomeruli
(A) OR genes identified by in vivo Ca2+ imaging followed by retrograde dye labeling and single-cell RT-PCR. The genes identified are shown in the
table (left). population indicates the number and percentage of OSNs in which the specific OR gene (indicated as OR gene in the list) was am-
plified by gene-specific primers. Between 47% and 71% of DiI-stained cells expressed the target OR genes. Representative RT-PCR products
amplified by each gene-specific primer are shown (right). Results from different animals are separated by vertical white lines. The nomenclature
for ORs is based on Zhang and Firestein, 2002.
(B) Single-glomerulus RT-PCR. The diagram depicts the method of single-glomerulus RT-PCR followed by isolation of odorant-activated glo-
meruli (left). RT-PCR products from single activated glomeruli are shown (right). The inability to amplify the MOR224-5 gene is probably due
to the low mRNA level in OSNs (see Figure 4A).
(C) Reconstitution of identified ORs in HEK293 cells. Representative Ca2+-response profiles of HEK293 cells expressing identified ORs are
shown. EG (1 mM), MIEG (1 mM), VA (300 mM), IVA (300 mM), or HA (300 mM) was applied for 15 s at the time indicated by arrows at intervals
of at least 2 min. VA, valeric acid; HA, heptanoic acid.we first peeled off the surface nerve layer and then
sucked up the target glomerulus with a sterilized capil-
lary tube (Figure 4B, left). As expected, each OR gene
fragment was specifically amplified from the cDNA of
a counterpart glomerulus (Figure 4B, right). MOR224-5
mRNA was not detected in glom. Eb, probably due to
a low level of mRNA in OSNs, as shown in Figure 4A. It
is of note that the target OR gene could not be amplified
after intrinsic imaging due to the lack of a positional
indicator.
Second, we examined the odorant responsiveness of
the identified ORs by expressing them in HEK293 cells
(Figure 4C). Increases in intracellular Ca2+ were observed
upon ligand stimulation of each OR when coexpressed
with Ga15 and receptor-transporting proteins (RTPs)
(Saito et al., 2004). Approximately 3% of total cells
were odorant-responsive for MOR224-9 and MOR224-5
(to 1 mM EG and MIEG),w5% for MOR224-13 (to 1 mM
EG), w15% for MOR31-2 (to 300 mM IVA), and w60%
for MOR204-34 (to 1 mM MIEG). The efficiency of odorant
responsiveness appears to vary greatly between ORs in
HEK293 cells. The Ca2+ responses were also observedwithout RTP proteins for MOR204-34 (w20% of total
cells) and MOR31-2 (w5%) (data not shown).
Odorant Response Properties of OR-Defined
Glomeruli
Next, we performed Ca2+ imaging in the OB to examine
in vivo odorant specificities of glom. Ea (MOR224-9),
glom. Eb (MOR224-5), glom. Ec (MOR224-13), and
glom. Ma (MOR204-34) using several odorants that are
structurally related to EG or MIEG. Figure 5A shows
the response of each glomerulus to the odorants in the
same animal. The response amplitudes evoked by stim-
ulation with various odorants were averaged and repre-
sented as a percentage of the maximum response in
each glomerulus (n = 6, Figure 5B).
Glom. Ea responded to a broad range of EG-related
odorants but not to methyl eugenol (MEG) or benzyl iso-
eugenol (BIEG). Glom. Eb had a similar response profile
to glom. Ea, except that acetyl IEG (AIEG) did not evoke
a response. Glom. Ec was activated not only by EG and
vanillin but also by BIEG and AIEG, which has relatively
high molecular weights. All three of these (glom. Ea, Eb,
Neuron
862Figure 5. In Vivo Odorant Response Specificity of OR-Defined Glomeruli
(A) Odorant response patterns of OR-defined glomeruli (glom. Ea, Eb, Ec, and Ma) from a single animal. F image indicates basal fluorescent im-
age of the OB illuminated at 500 nm. The responses are shown as pseudocolored images in which red corresponds to the greatest response. EG,
isoeugenol (IEG), and MIEG were used at 0.16 mM; guaiacol (G) at 0.4 mM; methyl EG (MEG), acetyl EG (AEG), benzyl IEG (BIEG), vanillin, and 4-
hydroxy 3-methyl benzaldehyde (4H3MBA) were used as neat substances.
(B) Summary of averaged response amplitudes of each glomerulus to the various odorants. The structures of the ten EG-related odorants used in
this experiment are shown above the table. The amplitudes of responses are averaged and shown as a percentage of maximum response of each
glomerulus evoked by 10% EG (for glom. Ea, Eb, and Ec) or 10% MIEG (for glom. Ma). Odorants that evoked no response were assigned a
response of <1%.and Ec) responded only to odorants that possess a ben-
zene ring and exhibited broad but overlapping ligand
specificities. Our observations support the contention
that glomeruli expressing homologous ORs within the
same subfamily tend to possess similar responsiveness
in vivo. In contrast to these three EG-sensitive glomeruli,
glom. Ma showed a relatively narrowly tuned response
spectrum, such that only MEG and MIEG evoked the
highest response. In addition, very small responses
were observed for acetyl EG and AIEG, but no response
was observed for compounds containing larger substit-
uent (BIEG). Our data demonstrate that MOR204-34 rep-
resented in glom. Ma has high selectivity for polarity and
size at the R4 position, such that a small ether group (es-
pecially a methoxy group) at the R4 position of the ben-
zene ring is required for ligand activity.
Spatial Distribution of OR-Defined Glomeruli
in the OB
For these five OR-defined glomeruli, we examined the
spatial distribution in the OB. The positional relationship
varied considerably between animals (Figures 6A and
S2). For example, glom. Ea was located posterior to
glom. Eb in 7 out of 17 animals, whereas this relative po-
sition was reversed in the other animals (Figure S2). The
positional reversal along the anterior-posterior axis was
frequently observed for every pair combination among
glom. Ea, Eb, and Ma. No correlation was found for the
position of each pair of glomeruli. In contrast, along
the lateral-medial axis, there was a high correlation be-
tween, for example, Ea and Ma (Ea was lateral to Ma in14/15 animals; r = 0.82) and between Ea and Eb (Ea
was lateral to Eb in 15/17 animals; r = 0.6). In addition,
the position of the glomeruli sometimes differed consid-
erably between the left and right OB (Figure 6A, lower).
No positional correlation was found between the left
and right glomeruli along the anterior-posterior or the
lateral-medial axis (n = 6 mice), suggesting that the po-
sitional relationship among glomeruli was not main-
tained between the left and right OBs.
Figure 6B shows the location of each glomerulus
based on the distances from the caudal sinus (x) and
the intersection of the midline (y) in millimeters. The av-
erage position of each glomerulus (x, y) was as follows:
(1.46 0.17, 1.66 0.14) for Ea, (1.46 0.17, 1.56 0.11) for
Eb, (2.1 6 0.18, 1.6 6 0.11) for Ec, (1.5 6 0.16, 1.5 6
0.14) for Ma, and (1.9 6 0.15, 0.98 6 0.08) for Ia. Each
glomerular domain occupied 5.2%, 3.8%, 6.8%, 3.3%,
and 2.2% (for glomeruli Ea, Eb, Ec, Ma, and Ia, respec-
tively) of the total imaged area (dotted line in Figure 6B).
These sizes were approximately the same or slightly
larger than the functional domain as previously defined
by glomerular activity patterns in the OB (Belluscio and
Katz, 2001; Uchida et al., 2000). Unlike the stereotyped
‘‘odor map,’’ our results show a precise bulbar ‘‘OR-
map’’ that appears to differ between individual animals.
Pharmacological Properties of ORs In Vivo
versus In Vitro
The response properties of glomeruli are thought to
reflect OR pharmacology observed in a heterologous
expression system or in isolated OSNs. To explore this
In Vivo Odorant Receptor Pharmacology
863Figure 6. Spatial Distribution of OR-Defined
Glomeruli in the OB
(A) Positional relationship between glomeruli
across animals and between left and right
OB. Odorant responses in both sides of the
OB are shown as pseudocolored images.
According to the pseudocolored response
maps (top), the bilateral location of each
OR-defined glomerulus is mapped onto the
OB (bottom). Some of the activated glomeruli
in the anterior region are out of focus in the
pseudocolored image (for comparison, see
Figure 3). Glom. Ea, Eb, Ec, and Ma are map-
ped by red, green, blue, and brown dots, re-
spectively. The coordinates of each glomeru-
lus were calculated as the distance from
the caudal sinus and the intersection of the
midline. See also Figure S2.
(B) Summary of the location of each glomeru-
lus in the OB from 10 to 17 preparations. Each
glomerulus is represented by the same color
as in Figure 6A. Scale bar, 500 mm.idea in more detail, we directly compared the in vivo li-
gand specificities of OR-defined glomeruli with the phar-
macological properties of ORs in vitro. We used mOR-
EG tagged with an additional sequence of 20 N-terminal
amino acids of bovine rhodopsin in this study, as no
difference was observed between tagged and intact
mOR-EG in the HEK293 cell line. For mOR-EG, vanillin
was a potent agonist at the receptor level in vitro (Figures
7A, left, and 7B). Specifically, the EC50 values were 51
mM for EG and 33 mM for vanillin in isolated OSNs (n =
3 cells) and 46 mM for EG and 26 mM for vanillin in
HEK293 cells (n = 4) (Figure 7B). In HEK293 cells, we ob-
served a difference in IEG-responsiveness as measured
by Ga15-mediated Ca
2+ imaging and Gas-mediated
cAMP elevation (Figure 7B), probably due to the differ-
ence in receptor coupling to Ga15 and Gas (Shirokova
et al., 2005).
In the mOR-EG glomerulus, however, we observed
a modest response or no response to vanillin and 4-
hydroxy-3-methyl benzaldehyde (4H3MBA), which are
potent agonists of mOR-EG-expressing OSNs and
HEK293 cells (Figure 7A, right, and 7B). The threshold
concentration for activation by vanillin in the mOR-EG-
glomerulus was w10-fold higher than that of EG, and
the maximum response evoked by neat crystal (0.29
mM vapor concentration) was 18.5% 6 4.9% (n = 3) ofthat elicited by 0.16 mM EG (7.7% dilution) (Figure 7B).
It was of particular interest that the odorant responsive-
ness of OSNs in vitro was different from that obtained in
vivo by Ca2+ imaging of axon terminals of OSNs in the
OB.
MOR204-34 (glom. Ma) also exhibited different re-
sponse profiles in vivo and in vitro. MOR204-34 was ro-
bustly activated by acetyl isoeugenol (AIEG) (300 mM) in
HEK293 cells (82.8%6 9.8% of the response elicited by
300 mM MIEG; n = 9), whereas only a small response was
observed in vivo by stimulation with AIEG in glom. Ma
(5.0% 6 3.7% of the response elicited by 45 nM MIEG)
(Figures 7C). The EC50 value for AIEG (55 mM) was
w2.5-fold higher than that of MIEG (21 mM) in HEK293
cells, whereas the threshold concentration of AIEG
wasw100-fold greater than that of MIEG as determined
by Ca2+ imaging in the OB (Figure 7C). No difference in
odorant responsiveness was observed in the results
obtained by Ca2+ imaging and those obtained by cAMP
elevation assay (Figure 7C).
Similar results were obtained for MOR224-5 (glom. Eb)
and MOR224-13 (glom. Ec). The ligand spectra were
slightly broader in HEK293 cells compared with those
in vivo for both ORs (Figure 7D). MOR224-13 was ob-
served to respond to MEG, and MOR224-5 responded
to MEG and 4H3MBA in HEK293 cells, whereas these
Neuron
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and In Vitro
(A) Odorant responses in mOR-EG glomeru-
lus and mOR-EG-expressing OSNs. Repre-
sentative responses evoked by EG, IEG,
MIEG, or vanillin (V) are shown (left, glomeru-
lus; right, isolated OSNs). The concentration
of odorants was adjusted to 0.16 mM in the
air phase or 300 mM in the aqueous solutions.
Scale bar, 30 mm (glomerulus) and 10 mm (iso-
lated OSNs).
(B) Dose-response analysis of mOR-EG. The
responses to EG (black line) and vanillin (red
line) in mOR-EG-expressing HEK293 cells
(left), isolated mOR-EG-expressing OSNs
(middle), and the mOR-EG-glomerulus (right)
were fitted to a dose-response curve. Each
response amplitude is shown as a percentage
of the maximum response. A summary of the
odorant responsiveness of mOR-EG is shown
in lower row. The results represent the aver-
age of DF from three to five mice (glomeru-
lus), ten cells (OSNs), or four to six assays
(HEK293 cells). Unless otherwise indicated,
the odorant concentration was adjusted to
0.16 mM in the air phase or 300 mM in aqueous
solution. a, tested at 0.19 mM (neat sub-
stance); b, tested at 0.4 mM.
(C) Dose-response of MOR204-34 in vivo and
in vitro. The responses to MIEG (black line)
and AIEG (red line) in MOR204-34-expressing
HEK cells (left, n = 9 cells), and glom. Ma
(right, n = 3 mice) were fit to a dose-response
curve (6SE). Summary of odorant respon-
siveness of MOR204-34 is shown in lower
row. The DF values were averaged. The con-
centration of odorants was adjusted to 45 nM
in the air phase or 300 mM in aqueous solu-
tion. Representative Ca2+ response profiles
in HEK293 cells and glomerulus are shown
(right).
(D) Ligand specificity of MOR224-5 and
MOR224-13. The concentration of odorants
was adjusted to 1 mM in aqueous solution.
The same concentrations as in Figure 5 were
used for OB imaging. Representative Ca2+
response profiles in HEK293 cells and glo-
merulus are shown (right).compounds failed to evoke responses in corresponding
glomeruli. We could not determine the specificity of
MOR224-9 because the response efficiency was not
high enough to allow careful specificity experiments
in HEK293 cells. These results clearly demonstrate that
in vivo odorant responsiveness at the level of the OB,
wherein odorants are delivered through the air, does
not necessarily exactly reflect the pharmacological
properties of the OR in a heterologous expression sys-
tem or in isolated OSNs, wherein odorants are delivered
through an aqueous solution without mucus.
Role of Olfactory Mucus in Odorant
Response Specificity
Finally, we examined the role of the olfactory mucus in
odorant responses in vivo. Using the artificial sniffingsystem (Wachowiak and Cohen, 2001), we recorded
odorant responses in the OB, washed the nasal cavity
with w5 ml Ringer’s solution to remove mucosal fluid
(Figure 8B), and recorded odorant responses again.
We found that the responses of vanillin were augmented
after washing out the mucus, whereas those of EG were
unaffected (Figure 8A). In the mOR-EG glomerulus, the
response amplitude (DF/F) of vanillin (neat) increased
from 0.37% 6 0.06% to 1.26% 6 0.23% (n = 3),
while that of EG (1%) was not significantly changed (from
1.39% 6 0.04% to 1.32% 6 0.02%, n = 3) (Figure 8C).
These results indicate that the mucus greatly influences
apparent odorant-responsiveness. The relative re-
sponse specificity was calculated by dividing the
amplitude of the vanillin response by that of the EG
response; the results were significantly different before
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(A) Odorant responses to EG (1%) and vanillin (neat) before/after washing out of mucus are shown as pseudocolored images (left). Represen-
tative Ca2+ response profiles evoked by EG or vanillin in the mOR-EG glomerulus are shown below the images. Dotted circles indicate the
position of the mOR-EG glomerulus.
(B) To assess the aqueous flow, DiI (0.02%) dissolved in Ringer’s solution was perfused into the nasal cavity. The DiI fluorescent signal was
visible throughout the OE (lower). No autofluorescence was observed at this wavelength. Upper, whole-mount view of the OE in bright field;
lower, DiI fluorescent signal.
(C) The response amplitude of mOR-EG glomerulus to EG and vanillin before or after washing out the mucus was shown (left, 6SE, n = 3). The
response ratio was calculated by dividing the response amplitude of vanillin by the EG response (right, 6SE, n = 3).and after washing the mucus (Figure 8C). Although it is
difficult to remove the mucus completely from the nasal
cavity, these results partly explain the difference be-
tween in vitro and in vivo OR responses.
Discussion
In this study, we used mOR-EG transgenic mice to es-
tablish a technique for functional OR identification
based on glomerular activity. Using this technique, we
directly linked in vivo glomerular activity in the OB with
the corresponding ORs. Extensive functional analysis
of OR-defined glomeruli revealed that the OR pharma-
cology in vitro is not exactly reflected by the in vivo re-
sponsiveness of the glomerulus in the OB. Thus, OR-
defined glomeruli tended to exhibit higher sensitivity and
specificity compared to the pharmacological properties
of the ORs in vitro. To our knowledge, we described
for the first time in vivo odorant responses at receptor
level and provided insights into our understanding of
how the in vivo OR code is formed under physiological
conditions.
Linking ORs with Odorant Response Properties
in Glomeruli
We developed a methodology for identifying the ORs
expressed in OSNs innervating activated glomeruli us-
ing Ca2+ imaging followed by retrograde dye labeling
and single-cell RT-PCR. Although this approach has
long been proposed (Bozza and Kauer, 1998; Mizrahiet al., 2004), to date, the ORs associated with specific
odorant-activated glomeruli have not been reliably iden-
tified. For several ORs, gene-targeted or transgenic
mice coexpressing fluorescent marker protein and an
OR of interest have been generated to visualize single
glomeruli in the OB. In a single case, using gene-tar-
geted mice in which the rat I7 receptor was ectopically
replaced with the intact M71 receptor gene, ligand odor-
ants were shown to activate rat I7 glomeruli in the mouse
OB (Belluscio et al., 2002). A detailed pharmacological
analysis of intact OR-defined glomeruli, however, has
not yet been performed.
In this study, we successfully linked five ORs with their
odorant responses in corresponding glomeruli. Impor-
tantly, we were able to identify ORs from all target glo-
meruli tested in this study (5/5 glomeruli), demonstrating
the high efficiency and reliability of our methodology.
The expression of the identified OR in the defined glo-
merulus was confirmed by single-glomerulus RT-PCR.
Moreover, the identified ORs expressed in HEK293 cells
recognized the odorants that were shown to elicit re-
sponses in the OB. Expansion of imaging areas in the
OB would allow us to determine a complete set of ORs
for a given odorant, which corresponds to an in vivo re-
ceptor code representing the odor quality of the odorant.
Odorant Sensitivity of OR In Vitro
versus Glomerulus In Vivo
It has long been known that odorant concentrations
required for activation of ORs in isolated OSNs or in
Neuron
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high; micromolar and sometimes millimolar concentra-
tions are used in aqueous solutions (Mombaerts,
2004). Indeed, the threshold concentrations of ligands
for ORs are reported to be 1026 to 1025 M in OSNs or
in HEK293 cells, suggesting that ORs are a relatively
low-affinity class of G protein-coupled receptor (Bozza
et al., 2002; Kajiya et al., 2001). In contrast to in vitro ex-
periments, much lower concentrations of odorants can
elicit responses in glomeruli in vivo, as assessed by im-
aging or behavioral responses (Lin et al., 2004; Mom-
baerts, 2004; Rubin and Katz, 1999). To address this dis-
crepancy, we directly compared the in vitro odorant
responsiveness of ORs in OSNs and in HEK293 cells
with the in vivo responsiveness in the corresponding
glomeruli. OR-defined glomeruli exhibited far higher
sensitivity to ligands (w1028 M in air phase) than in iso-
lated OSNs or HEK293 cells (see Figures 3 and 7). Our
Ca2+ imaging data demonstrated that the odorant sensi-
tivity of an OSN isolated from the OE was different from
the sensitivity of its axon terminal in the OB, raising the
possibility that the olfactory mucus, airflow rate, or
unique structure of the mammalian nasal cavity influ-
ences odorant responsiveness by helping to concen-
trate odorants (up to 1000-fold for EG) at a local receptor
site from the airflow. Consistently with this, an increase
in airflow in the nasal cavity during artificially controlled
sniffing resulted in greatly increased sensitivity in OR-
defined glomeruli, indicating that airflow rate is an im-
portant factor determining olfactory sensitivity in vivo
(unpublished data).
Odorant Specificity of OR In Vitro
versus Glomerulus In Vivo
Interestingly, the odorant specificity was also different in
the glomerulus and isolated OSNs. For example, vanillin
and 4-hydroxy-3-methyl-benzaldehyde evoked slight
responses in the mOR-EG glomerulus, whereas the
same concentrations of these odorants induced robust
responses in mOR-EG-expressing OSNs or HEK293
cells. Furthermore, vanillin was a slightly more potent
agonist than EG in isolated OSNs or in HEK293 cells,
whereas the relative potency was reversed in the OB
in vivo (Figure 6). Similar results were observed for
MOR204-34 (Figure 6D) as well as for MOR224-5 and
MOR224-13, clearly demonstrating that the in vivo re-
sponse in the OB does not faithfully reflect the in vitro
pharmacological properties of the OR.
Recent studies revealed a mechanism for inhibition of
presynaptic input via a neuronal circuit in the OB (Wa-
chowiak et al., 2005). Although this could explain our
observations, it is not likely in this case because presyn-
aptic inputs appear to be modulated only by intraglo-
merular inhibition and not by lateral inhibitory connec-
tions between glomeruli (McGann et al., 2005). Indeed,
we found that blocking of excitatory input from OSNs
by application of CNQX/APV had no significant effect
on the responses to vanillin or 4-hydroxy-3-methyl-
benzaldehyde in the axon terminal of OSNs (data not
shown), excluding the possibility of such an interneuro-
nal inhibition.
The alternative explanation for the difference between
the in vitro and in vivo responsiveness is the solubility of
odorants in olfactory mucus. Solubility in mucosal fluidis known to vary considerably between odorants de-
pending on their chemical properties (Kurtz et al.,
2004), which may result in different odorant concentra-
tions in the mucus. Interactions with mucosal proteins
such as odorant-binding proteins or metabolic enzymes
may also greatly affect the local concentration of an
odorant at the receptor site in vivo. Indeed, washing
out the mucus from the nasal cavity resulted in an aug-
mentation of the response to vanillin in the mOR-EG glo-
merulus, leading to changes in odorant specificity, which
partly explains the in vivo and in vitro discrepancy in re-
sponse specificity. Differences in local concentrations
of odorants may, therefore, lead to apparent changes
in odorant responsiveness in the OB. Since the in vivo
codes for odorants in the OB appear to be different than
the in vitro OR codes, we should be careful about relying
on combinatorial receptor-coding schemes based on in
vitro odorant-OR matrices obtained in mammalian cell
lines or isolated OSNs.
OR Map in the OB
In this study, we found that the position of five OR-
defined glomeruli greatly varied between animals re-
gardless of the similarity of the OR sequence or its ligand
specificity. Similarly, the relative position of glomeruli in-
nervated by OSNs expressing the mOR37 gene family
exhibits different local permutations (Strotmann et al.,
2000). Our positional correlation analysis revealed that
reversal of the relative position frequently occurred on
the anterior-posterior axis but rarely on the lateral-
medial axis. If glomerular positioning were totally ran-
dom, the frequency of positional reversal should be the
same for both axes. In light of this, our results indicate
that different factors may be involved in positioning rel-
ative to the anterior-posterior and lateral-medial axes
(Miyamichi et al., 2005). We also found positional dif-
ferences between left and right glomeruli in the same
animal, consistent with previously observed differences
in odorant activation patterns between the left and right
OBs (Belluscio and Katz, 2001). These results imply that
genetic background and odor experience have no ap-
parent effect on glomerular positioning. Further study
would be necessary to elucidate the effect of these
positional differences on individual odor perception, or
the factors determining relative glomerular position in
the OB. In this study, by examining the pattern of glo-
merular activity at the individual OR level, we demon-
strated that the OR map is not fixed in the OB, and there-
fore, the odor map in the OB can be truly described only
when repeatedly examined using multiple animals.
In summary, we successfully linked the glomerular ac-
tivity pattern to the corresponding ORs, and we mapped
these OR-defined glomeruli in the OB. By directly com-
paring the in vitro and in vivo OR responses, we demon-
strated that odorant specificity tends to be more nar-
rowly represented, with much higher sensitivity, in
glomeruli in vivo than in ORs in vitro. Our results also im-
ply an important role for the olfactory mucus in regulat-
ing odorant responsiveness under physiological condi-
tions. The current study describes a methodology that
enables exploration of the odor map in the OB at recep-
tor level and, therefore, provides previously unappreci-
ated implications for the in vivo odorant-recognition
mechanism.
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mOR-EG Transgenic Mice
Genomic clones containing mOR-EG were isolated from a Lambda
FIX phage library from a 129/SvJ mouse. The 8.0 kb KpnI/PvuII frag-
ment comprising the sequences between the KpnI site at 5.6 kb up-
stream of the mOR-EG start codon, and the PvuII site in the 30 un-
translated region (2.4 kb) was subcloned into pBluescript SK II
vector (Stratagene). A SacII-NotI site was engineered downstream
of the stop codon to produce plasmid mOR-EG/SacII/NotI. The
SacII/NotI insert of IRES-gapEGFP, which encodes an internal ribo-
some entry site (IRES) and a fusion protein consisting of the N-termi-
nal 20 amino acids of GAP-43 and EGFP, was ligated to generate the
transgene mOR-EG-IRES-gapEGFP. Gel-purified transgenes were
microinjected into the pronucleus of fertilized eggs that were ob-
tained from mating C57BL/6 and DBA/2J mice. Founders were
bred with C57BL/6 mice. All animal experiments were approved by
the Animal Care Committee of the University of Tokyo.
In three lines, we found different GFP expression patterns in the
OB (Figure S1). Despite the line variation, the main GFP-positive glo-
merulus was observed in the dorsal OB in all lines, and we observed
no differences in odorant responsiveness of the main glomerulus
between the lines. The data from each line were thus pooled for
quantitative analysis.
Recording of Odorant Responses in the OB
Ca2+ imaging and intrinsic imaging in the OB were performed on 4-
to 8-week-old C57BL/6 mice or mOR-EG transgenic mice as de-
scribed previously (Fried et al., 2002; Rubin and Katz, 1999; Uchida
et al., 2000; Wachowiak and Cohen, 2003). For Ca2+ imaging, OSNs
were loaded with CG-1 dextran (Molecular Probes, Eugene, OR). Un-
der anesthesia with ketamine (90 mg/kg) and xylazine (10 mg/kg), 1.5
ml of dye solution (6% in Ca2+-free Ringer’s solution) was perfused
into the nasal cavity using a shortened gel-loading tip. Perfusion
was repeated at 3 min intervals until a total volume of 6–8 ml was in-
jected. This volume was sufficient to load the OSNs innervating the
overall dorsal part of the OB with enough fluorescent dye to provide
a strong signal. Bilateral imaging was performed in six mice by per-
fusing both sides of the nasal cavity with dye solution. Ca2+ imaging
was performed 3–7 days after dye loading.
Mice were anesthetized by subcutaneous injection of ketamine
(70 mg/kg) and medetomidine (0.5 mg/kg). Using a dental drill, the
skull overlying the dorsal surface of the OB was thinned and re-
moved while leaving the dura intact. The exposed area was then
filled with 1.5% agarose gel and covered with a cover glass. Be-
cause a significant difference was not observed in odorant-evoked
spatial patterns between artificially sniffing (3.3 Hz) and freely
breathing (w2.5 Hz) animals, all experiments were performed under
the freely breathing condition. The breathing rate was between 2.0
and 2.5 Hz during the experiments. For fluorescent Ca2+ imaging
in the OB of C57BL/6 mice, the excitation wavelength was 500 6
25 nm, and emitted light at wavelengths above 530 nm was collected
using a 525 nm dichroic mirror. For mOR-EG transgenic mice, the
CG-1 signal was separated from the GFP signal using a custom-
made filter and a 560 nm dichroic mirror with excitation at 537 6
15 nm and emission at 565 nm. This filter had no effect on the relative
signal amplitude (DF/F). For intrinsic imaging, the OB was illumi-
nated at 650 nm and the reflected light was collected. Images
were acquired using AQUA COSMOS software and an ORCA2-ER
CCD camera (Hamamatsu Photonics, Hamamatsu, Japan) with a
resolution of 672 3 522 pixels at 12 Hz (for Ca2+ imaging) or 1344 3
1044 pixels at 9 Hz (for intrinsic imaging). The imaging area was
2.3 3 1.4 mm using a 103 objective lens and 5.6 3 3.4 mm using
a 43 objective lens.
Odorants
Odorants utilized in this study were kindly provided by T. Hasegawa
Co. Ltd. (Tokyo, Japan) or purchased from Sigma (Tokyo, Japan).
The purity of some odorants was checked by thin layer chromatog-
raphy or GC-MS. Odorants were prepared in a 5 ml glass tube either
as a pure substance or diluted in DMSO (vanillin and IEG) or mineral
oil (other odorants). Because the theoretical vapor concentration
sometimes differs greatly from the actual concentration, we directly
measured the vapor concentration of each odorant (both puresubstance and diluted form) by GC-MS (Shimadzu, Tokyo, Japan)
as described in Figure S3.
Data Analysis
For Ca2+ imaging, data from each trial were analyzed individually.
For intrinsic imaging, we averaged three consecutive odorant-
evoked responses to improve the signal-to-noise ratio. The relative
signal amplitude was calculated as described previously (Wacho-
wiak and Cohen, 2001). Briefly, the fluorescence or the reflectance
of each pixel at the peak of the response was subtracted from the
resting signal intensity just before the stimulus and then divided
by the resting intensity to adjust for unequal dye labeling or uneven
illumination. In analyses of dose-dependence, the DF/F value was
quantified and is represented as a percentage of the maximum re-
sponse in each glomerulus, typically evoked by one of the following:
10% EG in the mOR-EG glomerulus and glom. Ea, Eb, and Ec; 10%
MIEG in glom. Ma; or 0.1% IVA in glom. Iva.
Spatial maps were constructed from each pixel’s signal by sub-
tracting the temporal average of a time window just preceding the
stimulus (t1) from a temporal average centered near the peak of
the response (t2), and then divided by temporal average of t1. To
construct odor maps, we averaged 2.7–4.6 s for t1 and 5.5–7.8 s
(Ca2+ imaging) or 6.8–9.5 s (intrinsic imaging) for t2. After construct-
ing the map, a Gaussian spatial filter was used for intrinsic imaging
to eliminate the nonspecific responses (SD = 68 mm). For generation
of figures, all maps were smoothed using a 3 3 3 pixel kernel and
normalized to the maximum signal amplitude (maxDF/F) for the trial.
All spatial data were analyzed and processed using AQUA COSMOS
software (Hamamatsu photonics) and Photoshop (Adobe).
The positional correlation between glomeruli was measured by
comparing each position of the glomerulus. The glomerulus position
was determined as a coordinate represented by the distance (mm)
from the caudal sinus (x) and the intersection of the midline (y) as
previously described (Belluscio and Katz, 2001). After mapping
each glomerulus in the OB, we analyzed the correlation between
each pair of glomeruli across animals or between left and right OB
for the anterior-posterior and lateral-medial axes. Correlation analy-
sis was performed using Prism software (Graphpad Software).
Ca2+ Imaging of HEK293 Cells
Ca2+ imaging in HEK293 cells was performed essentially as de-
scribed previously (Katada et al., 2003). Briefly, 60%–70% confluent
HEK293 cells were transfected with 2.5 mg of pME18S-tagged-ORs,
1.5 mg of pME18S-Ga15, and 0.5 mg of RTPs using Lipofectamine
2000 (Invitrogen; 2.5 ml/mg DNA). All ORs contained additional N-ter-
minal 20 amino acids of bovine rhodopsin. After 24–28 hr, the trans-
fected cells were loaded with 2.5 mM Fura-2/AM for 30 min at 37C.
Odorant solutions were sequentially applied to the cells using a peri-
staltic pump at a flow rate of 1.5 ml/min for 15 s with aw2 min wash
with Ringer’s solution between stimuli.
Ca2+ Imaging of Mouse Olfactory Neurons
Olfactory neurons for Ca2+ imaging were isolated from the OE of
4- to 8-week-old mOR-EG transgenic mice on Cell-TAK-coated
glass-bottomed dishes, and Fura-2-based Ca2+ responses were
recorded as described previously (Oka et al., 2004b). The odorant
responses were recorded from GFP-positive cells. Odorant solu-
tions were sequentially applied for 10 s with a 2.5 min wash between
stimuli.
Measurement of the cAMP Level in HEK293 Cells
The level of cAMP in HEK293 cells was measured essentially as de-
scribed previously (Katada et al., 2003). Briefly, 60%–70% confluent
HEK293 cells were transfected with 2.5 mg of pME18S-tagged-ORs
and 0.5 mg of RTPs using Lipofectamine 2000 (Invitrogen; 2.5 ml/mg
DNA). After 24 to 28 hr, cells were stimulated with odorants for
5 min, and the intracellular cAMP level was monitored using a
cAMP-Screen kit (Tropix).
DiI Injection into aGlomerulus and Isolation of InnervatingOSNs
After Ca2+ imaging in the OB, the center of the odorant-activated
glomerulus was pressure-injected with 3% DiI in dimethyl formam-
ide using a glass capillary (w2 mm in diameter). The injection volume
was less than 0.1 ml, which corresponded to 50%–80% of the total
Neuron
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ously illuminated at 500 nm to visualize both the CG-1 signal and
the DiI signal. Injection of a larger volume resulted in staining of non-
targeted glomeruli.
After 24–36 hr, mice were anesthetized by overdose with Mioblock
(Sankyo, Japan), and the most dorsal region of the OE (zone 1) was
dissociated in Ringer’s solution. Longer recovery times (48 hr) after
DiI injection caused changes in the properties of the cell membrane,
making it difficult to collect the target cell. The OSN layer was then
peeled off the epithelium with scalpel and forceps and cut into
pieces. After gently triturating the pieces 8 to 12 times, dissociated
cells were transferred to a glass-bottomed 35 mm dish coated with
Cell-Tak (Collaborative Research, Bedford, MA) and allowed to set-
tle and attach for approximately 15 min. To remove contaminating
mRNA released during trituration, isolated OSNs were washed
with Ringer’s solution for at least 20 min using a peristaltic pump.
DiI-stained OSNs were individually collected with a glass capillary
(w10 mm in diameter) for subsequent single-cell RT-PCR.
Isolation of Single Glomeruli
To isolate mRNA from single glomeruli, the odorant-activated glo-
merulus was precisely located after in vivo Ca2+ imaging using the
CG-1 signal as a landmark. Mice were then sacrificed by an over-
dose with Mioblock, and the dura covering the dorsal surface of
the OB was carefully removed with forceps. We typically used two
capillaries (w30 mm in diameter) to collect each glomerulus. First,
the nerve layer covering the target glomerulus was removed under
a fluorescent microscope using a glass capillary, and then the OB
was washed with Ringer’s solution. Second, the exposed target glo-
merulus was directly collected with another capillary (w0.1 ml in vol-
ume). To avoid contamination from axons innervating neighboring
glomeruli, we picked a portion rather than the whole glomerulus.
Collected axons were used for subsequent single-glomerulus RT-
PCR. Although this method ensured that identified glomeruli ex-
pressed OR genes, we were rarely able to amplify OR genes with de-
generate primers because of the small amount of mRNA in the axon
terminal.
Artificial Sniffing and Removal of Mucus from Nasal Cavity
A double tracheotomy was conducted essentially as previously de-
scribed (Wachowiak and Cohen, 2001). An artificial sniffing system
was used to control odorant access and wash out the mucus from
nasal cavity. The naris on the side at which CG-1 was injected was
left open. For Ca2+ imaging, the upper tracheotomy tube was vac-
uumed with negative pulse pressure (50 ml/min flow rate, 150 ms du-
ration, 3.3 Hz) for odorant presentation. After recording, the nasal
cavity was washed with w5 ml Ringer’s solution using negative
pressure (w30 ml/min) through the upper tracheotomy tube. Within
15 min after washing out the mucus, odorant responses were re-
corded again and compared with those obtained before washing.
Although the effect of the mucus removal is known to continue at
least 30 min and recover within a few hours (Weiler et al., 2006), it
was difficult to precisely assess the removal efficiency because
the mucosal fluid is continuously secreted from glands in the nasal
cavity.
RT-PCR
Isolated DiI-positive OSNs or odorant-activated single glomeruli
were analyzed by RT-PCR essentially as described previously
(Oka et al., 2004b) but with slight modifications. After OSNs or glo-
meruli were isolated in a glass microcapillary, the crude RNA was
isolated from them using a Micro-to-Midi Total RNA Purification Sys-
tem (Invitrogen). The cDNA generated from each sample was PCR-
amplified using gene-specific primers or the following degenerate
primers: D1, ACGGATCCATGGCCTACGACCGGTACGTNGCNAT
HTG; D2, ACCTCGAGTGGGAGGCGCAGGTGSWRAANGCYTT; D3,
ATGKSITWIGAYMGITWYGYIGC; D4, TWIGAYMGITWYGYIGCIRT
ITG; or D5, TAIAYIAIIGGRTTIAGCAWIGG; NotI, NotI-adaptor primer
pair based on d(T)18-NotI used for the first-strand cDNA synthesis.
A first amplification was performed usingD1,D3, or a specific primer
and NotI. The second amplification was performed using D1 and D2,
D4 and D5, or specific primer pairs. The first and second amplifica-
tions were carried out using 2.5 units/50 ml ExTaq (Takara) and with
the following reaction conditions: for D1 and D2 primers, 95C for30 s, followed by 40 cycles of 95C for 30 s, 40C for 30 s, and
72C for 1 min; or for D3, D4, and D5 primers, 95C for 30 s, followed
by 40 cycles of 95C for 30 s, 45C for 90 s, and 72C for 1 min.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/5/857/DC1/.
Acknowledgments
We thank T. Hasegawa Co. Ltd. for odorant compounds, members
of K. Mori’s lab for advice on the medetomidine anesthesia proto-
col, N. Uchida for technical advice on olfactory bulb surgery, and
Touhara’s lab members for support. This work was supported in
part by grants from the Program for Promotion of Basic Research
Activities for Innovative Biosciences, Japan (PROBRAIN) (to K.T.),
Grant-in-Aid for Scientific Research from the Ministry of Education,
Culture, Sports, Science, and Technology of Japan (to Y.Y. and
K.T.), the Japan Society for the Promotion of Science (JSPS) (to
Y.O.), and Regional Research and Development Consortium
Project (to K.T.).
Received: May 25, 2006
Revised: October 5, 2006
Accepted: October 19, 2006
Published: December 6, 2006
References
Araneda, R.C., Kini, A.D., and Firestein, S. (2000). The molecular re-
ceptive range of an odorant receptor. Nat. Neurosci. 3, 1248–1255.
Belluscio, L., and Katz, L.C. (2001). Symmetry, stereotypy, and to-
pography of odorant representations in mouse olfactory bulbs.
J. Neurosci. 21, 2113–2122.
Belluscio, L., Lodovichi, C., Feinstein, P., Mombaerts, P., and Katz,
L.C. (2002). Odorant receptors instruct functional circuitry in the
mouse olfactory bulb. Nature 419, 296–300.
Bozza, T.C., and Kauer, J.S. (1998). Odorant response properties
of convergent olfactory receptor neurons. J. Neurosci. 18, 4560–
4569.
Bozza, T., Feinstein, P., Zheng, C., and Mombaerts, P. (2002). Odor-
ant receptor expression defines functional units in the mouse olfac-
tory system. J. Neurosci. 22, 3033–3043.
Buck, L.B. (2004). Olfactory receptors and odor coding in mammals.
Nutr. Rev. 62, S184–S188.
Buck, L., and Axel, R. (1991). A novel multigene family may encode
odorant receptors: a molecular basis for odor recognition. Cell 65,
175–187.
Chess, A., Simon, I., Cedar, H., and Axel, R. (1994). Allelic in-
activation regulates olfactory receptor gene expression. Cell 78,
823–834.
Firestein, S. (2004). A code in the nose. Sci. STKE 2004, pe15.
Fried, H.U., Fuss, S.H., and Korsching, S.I. (2002). Selective imaging
of presynaptic activity in the mouse olfactory bulb shows concentra-
tion and structure dependence of odor responses in identified
glomeruli. Proc. Natl. Acad. Sci. USA 99, 3222–3227.
Guthrie, K.M., and Gall, C.M. (1995). Functional mapping of odor-
activated neurons in the olfactory bulb. Chem. Senses 20, 271–282.
Johnson, B.A., and Leon, M. (2000). Modular representations of
odorants in the glomerular layer of the rat olfactory bulb and the ef-
fects of stimulus concentration. J. Comp. Neurol. 422, 496–509.
Kajiya, K., Inaki, K., Tanaka, M., Haga, T., Kataoka, H., and Touhara,
K. (2001). Molecular bases of odor discrimination: Reconstitution of
olfactory receptors that recognize overlapping sets of odorants.
J. Neurosci. 21, 6018–6025.
Katada, S., Nakagawa, T., Kataoka, H., and Touhara, K. (2003). Odor-
ant response assays for a heterologously expressed olfactory
receptor. Biochem. Biophys. Res. Commun. 305, 964–969.
Katada, S., Hirokawa, T., Oka, Y., Suwa, M., and Touhara, K. (2005).
Structural basis for a broad but selective ligand spectrum of a mouse
In Vivo Odorant Receptor Pharmacology
869olfactory receptor: mapping the odorant-binding site. J. Neurosci.
25, 1806–1815.
Kurtz, D.B., Zhao, K., Hornung, D.E., and Scherer, P. (2004). Exper-
imental and numerical determination of odorant solubility in nasal
and olfactory mucosa. Chem. Senses 29, 763–773.
Lin, W., Arellano, J., Slotnick, B., and Restrepo, D. (2004). Odors
detected by mice deficient in cyclic nucleotide-gated channel
subunit A2 stimulate the main olfactory system. J. Neurosci. 24,
3703–3710.
Luu, P., Acher, F., Bertrand, H.O., Fan, J., and Ngai, J. (2004). Molec-
ular determinants of ligand selectivity in a vertebrate odorant recep-
tor. J. Neurosci. 24, 10128–10137.
Malnic, B., Hirono, J., Sato, T., and Buck, L.B. (1999). Combinatorial
receptor codes for odors. Cell 96, 713–723.
McGann, J.P., Pirez, N., Gainey, M.A., Muratore, C., Elias, A.S., and
Wachowiak, M. (2005). Odorant representations are modulated
by intra- but not interglomerular presynaptic inhibition of olfactory
sensory neurons. Neuron 48, 1039–1053.
Miyamichi, K., Serizawa, S., Kimura, H.M., and Sakano, H. (2005).
Continuous and overlapping expression domains of odorant recep-
tor genes in the olfactory epithelium determine the dorsal/ventral
positioning of glomeruli in the olfactory bulb. J. Neurosci. 25,
3586–3592.
Mizrahi, A., Matsunami, H., and Katz, L.C. (2004). An imaging-based
approach to identify ligands for olfactory receptors. Neuropharma-
cology 47, 661–668.
Mombaerts, P. (2004). Genes and ligands for odorant, vomeronasal
and taste receptors. Nat. Rev. Neurosci. 5, 263–278.
Mombaerts, P., Wang, F., Dulac, C., Chao, S.K., Nemes, A., Mendel-
sohn, M., Edmondson, J., and Axel, R. (1996). Visualizing an olfac-
tory sensory map. Cell 87, 675–686.
Mori, K., Takahashi, Y.K., Igarashi, K.M., and Yamaguchi, M. (2006).
Maps of odorant molecular features in the mammalian olfactory
bulb. Physiol. Rev. 86, 409–433.
Oka, Y., Nakamura, A., Watanabe, H., and Touhara, K. (2004a). An
odorant derivative as an antagonist for an olfactory receptor.
Chem. Senses 29, 815–822.
Oka, Y., Omura, M., Kataoka, H., and Touhara, K. (2004b). Olfactory
receptor antagonism between odorants. EMBO J. 23, 120–126.
Ressler, K.J., Sullivan, S.L., and Buck, L.B. (1994). Information
coding in the olfactory system: evidence for a stereotyped and
highly organized epitope map in the olfactory bulb. Cell 79, 1245–
1255.
Rubin, B.D., and Katz, L.C. (1999). Optical imaging of odorant repre-
sentations in the mammalian olfactory bulb. Neuron 23, 499–511.
Saito, H., Kubota, M., Roberts, R.W., Chi, Q., and Matsunami, H.
(2004). RTP family members induce functional expression of mam-
malian odorant receptors. Cell 119, 679–691.
Serizawa, S., Ishii, T., Nakatani, H., Tsuboi, A., Nagawa, F., Asano,
M., Sudo, K., Sakagami, J., Sakano, H., Ijiri, T., et al. (2000). Mutually
exclusive expression of odorant receptor transgenes. Nat. Neurosci.
3, 687–693.
Shepherd, G.M. (1994). Discrimination of molecular signals by the
olfactory receptor neuron. Neuron 13, 771–790.
Shirokova, E., Schmiedeberg, K., Bedner, P., Niessen, H., Willecke,
K., Raguse, J.D., Meyerhof, W., and Krautwurst, D. (2005). Identifica-
tion of specific ligands for orphan olfactory receptors. G protein-
dependent agonism and antagonism of odorants. J. Biol. Chem.
280, 11807–11815.
Strotmann, J., Conzelmann, S., Beck, A., Feinstein, P., Breer, H., and
Mombaerts, P. (2000). Local permutations in the glomerular array of
the mouse olfactory bulb. J. Neurosci. 20, 6927–6938.
Touhara, K. (2002). Odor discrimination by G protein-coupled olfac-
tory receptors. Microsc. Res. Tech. 58, 135–141.
Touhara, K., Sengoku, S., Inaki, K., Tsuboi, A., Hirono, J., Sato, T.,
Sakano, H., and Haga, T. (1999). Functional identification and recon-
stitution of an odorant receptor in single olfactory neurons. Proc.
Natl. Acad. Sci. USA 96, 4040–4045.Uchida, N., Takahashi, Y.K., Tanifuji, M., and Mori, K. (2000). Odor
maps in the mammalian olfactory bulb: domain organization and
odorant structural features. Nat. Neurosci. 3, 1035–1043.
Vassalli, A., Rothman, A., Feinstein, P., Zapotocky, M., and
Mombaerts, P. (2002). Minigenes impart odorant receptor-specific
axon guidance in the olfactory bulb. Neuron 35, 681–696.
Vassar, R., Chao, S.K., Sitcheran, R., Nunez, J.M., Vosshall, L.B., and
Axel, R. (1994). Topographic organization of sensory projections to
the olfactory bulb. Cell 79, 981–991.
Wachowiak, M., and Cohen, L.B. (2001). Representation of odorants
by receptor neuron input to the mouse olfactory bulb. Neuron 32,
723–735.
Wachowiak, M., and Cohen, L.B. (2003). Correspondence between
odorant-evoked patterns of receptor neuron input and intrinsic
optical signals in the mouse olfactory bulb. J. Neurophysiol. 89,
1623–1639.
Wachowiak, M., McGann, J.P., Heyward, P.M., Shao, Z., Puche,
A.C., and Shipley, M.T. (2005). Inhibition [corrected] of olfactory
receptor neuron input to olfactory bulb glomeruli mediated by sup-
pression of presynaptic calcium influx. J. Neurophysiol. 94, 2700–
2712.
Weiler, E., Deutsch, S., and Apfelbach, R. (2006). Combined behav-
ioral and c-Fos studies elucidate the vital role of sodium for odor
detection. Chem. Senses 31, 641–647.
Wetzel, C.H., Oles, M., Wellerdieck, C., Kuczkowiak, M., Gissel-
mann, G., and Hatt, H. (1999). Specificity and sensitivity of a human
olfactory receptor functionally expressed in human embryonic
kidney 293 cells and Xenopus Laevis oocytes. J. Neurosci. 19,
7426–7433.
Xu, F., Kida, I., Hyder, F., and Shulman, R.G. (2000). Assessment and
discrimination of odor stimuli in rat olfactory bulb by dynamic func-
tional MRI. Proc. Natl. Acad. Sci. USA 97, 10601–10606.
Xu, F., Liu, N., Kida, I., Rothman, D.L., Hyder, F., and Shepherd, G.M.
(2003). Odor maps of aldehydes and esters revealed by functional
MRI in the glomerular layer of the mouse olfactory bulb. Proc. Natl.
Acad. Sci. USA 100, 11029–11034.
Zhang, X., and Firestein, S. (2002). The olfactory receptor gene
superfamily of the mouse. Nat. Neuorsci. 5, 124–133.
Zheng, C., Feinstein, P., Bozza, T., Rodriguez, I., and Mombaerts, P.
(2000). Peripheral olfactory projections are differentially affected in
mice deficient in a cyclic nucleotide-gated channel subunit. Neuron
26, 81–91.
